Desk›Healthcare› Amanta Healthcare Ltd
Amanta Healthcare Ltd
BSE 544502 · NSE AMANTA · ISIN INE084K01015 · Group T · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹183.55
-1.95%
BSE close, 28 August 2026
₹712.71 cr
3.9 cr shares · Micro cap
₹130.85 cr
as published
48.6× · —
EPS ₹3.78 · BV —
287.68 / 14.88
₹ cr, as filed
29
6 selected · 21%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -10.5% |
|---|---|
| Against 52-week low | +97.2% |
| Day change | -1.95% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹3.78 |
|---|---|
| Price / earnings | 48.56× |
| Price / book | — |
| Book value — derived, price ÷ P/B | — |
| Return on equity | — |
| Operating margin | 22.07% |
| Net margin | 4.81% |
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 68.80 | 3.31 | 0.85 | 22.07% | 4.81% |
| Mar-26 · Q | 77.00 | 5.53 | 1.61 | 21.58% | 7.18% |
| FY25-26 | 287.68 | 14.88 | 4.33 | 21.07% | 5.17% |
Quarter on quarter
- Revenue, quarter on quarter
- -10.6%
- Net profit, quarter on quarter
- -40.1%
- Operating margin, quarter on quarter
- +49 bps
Disclosure profile 29 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Change in Management | 2 |
| Board Outcome | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 6 |
| Procedural | |
| General | 7 |
| AGM / EGM | 4 |
| Newspaper Publication | 3 |
| SAST | 3 |
| Analyst / Investor Meet | 2 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Trading Window | 1 |
| Procedural sub-total | 23 |
| Total | 29 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group T, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
29 filings · 6 selected · busiest 2026-08-05
Filing rhythm · the twelve most recent
2026-09-032026-10-06
SelectedProcedural
Filings
29 in the window · 9 earlier on record
-
6 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
5 October 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pravinchandra Mehta
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
1 October 2026 ·
Submission Of Disclosures Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015 - Off Market Transfer Of Equity Shares
Submission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 - Off-Market Transfer of Equity shares
Company Update / General View filing →
-
1 October 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kirit Desai
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
30 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pravinchandra Mehta
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
30 September 2026 ·
Submission Of Disclosures Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015 - Off Market Transfer Of Equity Shares
Submission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 - Off Market transfer of equity shares
Company Update / General View filing →
-
24 September 2026 ·
Closure of Trading Window
Intimation under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015
Insider Trading / SAST / Closure of Trading Window View filing →
-
16 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Scrutinizer's Report and E-voting Results - Outcome of AGM
AGM/EGM / AGM View filing →
-
16 September 2026 ·
Shareholder Meeting - Scrutinizer's Report
Scrutinizer's Report and E-Voting results for the 31st Annual General Meeting of the Company
AGM/EGM / AGM View filing →
-
16 September 2026 ·
Change in Management
Announcement under Regulation 30 (LODR) - change in management
Company Update / Change in Management View filing →
-
16 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 31st Annual General Meeting ("AGM")
AGM/EGM / AGM View filing →
-
3 September 2026 ·
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Newspaper publication
Company Update / General View filing →
-
2 September 2026 ·
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Amanta Healthcare Limited Announces Commissioning Of New Steriport Line
Amanta Healthcare Limited Announces Commissioning of New SteriPort Line
Company Update / General View filing →
-
25 August 2026 ·
Intimation - Regulation 36(1)(B) Of The SEBI Listing Regulations
Intimation - Regulation 36(1)(b) of the SEBI Listing Regulations
Company Update / General View filing →
-
25 August 2026 ·
Newspaper Publication
Newspaper Advertisement for dispatch of Annual Report of the 31st Annual General Meeting and e-voting information
Company Update / Newspaper Publication View filing →
-
24 August 2026 ·
Annual Report For Financial Year 2025-26
Annual Report for Financial Year 2025-26
Company Update / General View filing →
-
24 August 2026 ·
Notice Of 31St Annual General Meeting And Annual Report For F.Y. 2025-26
Notice of 31st Annual General Meeting and Annual Report for F.Y. 2025-26
AGM/EGM / AGM View filing →
-
24 August 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for Financial Year 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
12 August 2026 ·
Newspaper Publication
Submission of Newspaper clippings - Advertisement addressed to the Shareholders for Annual General Meeting
Company Update / Newspaper Publication View filing →
-
7 August 2026 ·
Newspaper Publication
Publication of Financial Results in Newspapers
Company Update / Newspaper Publication View filing →
-
6 August 2026 ·
Analyst / Investor Meet - Outcome
Submission of Audio Recording of Post Results Conference Call held on August 6, 2026
Company Update / Analyst / Investor Meet View filing →
-
5 August 2026 ·
Press Release / Media Release
Announcement under Reg 30- Press Release
Company Update / Press Release / Media Release View filing →
-
5 August 2026 ·
Statement Of Deviation Or Variation In Utilization Of Funds, If Any, Under Regulation 32 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
Statement of Deviation or Variation in utilization of funds, if any
Company Update / General View filing →
-
5 August 2026 ·
-
5 August 2026 ·
To Approve Unaudited Financial Results For The Quarter Ended 30Th June 2026
To approve unaudited Financial Results for the Quarter ended 30th June 2026
Result / Financial Results View filing →
-
5 August 2026 ·
Board Meeting Outcome for To Approval Unaudited Financial Results For Quarter Ended 30Th June 2026
To approve unaudited Financial Results for quarter ended 30th June 2026
Board Meeting / Outcome of Board Meeting View filing →
-
5 August 2026 ·
Change in Management
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 for change in Senior Management Personnel of the Company
Company Update / Change in Management View filing →
-
3 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of the Earnings Conference Call for Q1 ended June 30, 2026
Company Update / Analyst / Investor Meet View filing →
-
29 July 2026 ·
Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter Ended June 30, 2026
Amanta Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Considering And Approving ....
Board Meeting / Board Meeting View filing →
RSS feed for Amanta Healthcare Ltd · the 50 most recent filings